Pressemitteilungen

BIOTRONIK Announces Results of BIOFLEX-I Trial at the Cardiovascular Research Technologies Conference in Washington, DC

, Medical Technology

BIOTRONIK, a leading manufacturer of cardio- and endovascular medical devices, today announced the presentation of promising data from the iliac...

BIOTRONIK Advances Clinical Evaluation of Latest Generation DREAMS, World's First Bioabsorbable Magnesium Scaffold

, Medical Technology

BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, announced the completion of enrollment in the BIOSOLVE-II trial...

Meilenstein in BIOSOLVE-II-Studie zur klinischen Prüfung des ersten bioresorbierbaren Gefäßgerüsts auf Magnesiumbasis erreicht

, Medical Technology

BIOTRONIK, ein führender Hersteller kardio- und endovaskulärer Medizintechnik, gab die Aufnahme des letzten Patienten in die BIOSOLVE-II-Studie...

ProMRI Studies Confirm Safety of MR Imaging with BIOTRONIK Devices - Results Published in Heart Rhythm Journal

, Medical Technology

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today that its ProMRI and ProMRI AFFIRM studies have been published...

バイオトロニックが、オシロ(Orsiro)薬剤溶出ステントの 安全性と有効性を評価するBIOFLOW-IV試験の症例登録を完了

, Medical Technology

心血管医療機器におけるリーディング企業で­あるバイオトロニック(日本本社:東京)は­、日本の承認申請のために実施しているBI­OFLOW-IV試験の症例登録が完了したことを発表し­ました。本試験で評価されるオシロ・ハイブ­リッド薬剤溶出ステントは、2011年にC­Eマークを取得した第3世代の薬剤溶出ステ­ントです。 BIOFLOW-IV試験は、40施設以上が参加している国­際共同無作為化試験です。 冠動脈病変を持­つ患者の登録後1年経過時の標的血管不全(­TVF)を主要評価項目としてアボット社の­Xience...

BIOTRONIK Announces Completion of Patient Enrollment in BIOFLOW-IV Study Evaluating Safety and Efficacy of Orsiro

, Medical Technology

BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, announced today that patient enrollment for the BIOFLOW-IV...

El análisisdel REPLACE DARE proporciona una herramienta novedosa para calcular el riesgo de los pacientes que necesitan sustituir su marcapasos o DAI

, Medical Technology

BIOTRONIK, uno de los fabricantes líderes en tecnología médica cardiovascular, anunció hoy la publicación de nuevos descubrimientos del registro...

Le Score REPLACE DARE constitue un outil innovant pour identifier les facteurs de risque de mortalité chez les patients nécessitant un remplacement de leur stimulateur cardiaque ou de leur DAI

, Medical Technology

L'analyse de l'étude REPLACE, sponsorisée par BIOTRONIK, permet d'identifier les principaux facteurs prédictifs de la mortalité après un remplacement...

O REPLACE DARE Score é uma ferramenta inovadora para estratificação do risco nos pacientes candidatos a troca de marcapasso ou CDI

, Medical Technology

A BIOTRONIK, fabricante líder de tecnologia cardiovascular, anunciou hoje a publicação de novos dados do Registo REPLACE no jornal Circulation:...

BIOTRONIK annuncia i primi arruolamenti di pazienti al nuovo studio per la valutazione della riduzione degli eventi tromboembolici tramite ablazione con GoldTip

, Medical Technology

BIOTRONIK, produttore leader nel settore della tecnologia medica cardiovascolare, ha annunciato oggi i primi arruolamenti di pazienti al suo...

BIOTRONIK anuncia las primeras inclusiones en un nuevo estudio que evalúa la reducción de incidencias tromboembólicas mediante la ablación con punta de oro

, Medical Technology

BIOTRONIK, un fabricante líder de tecnología médica cardiovascular, ha anunciado hoy las primeras inclusiones en su estudio piloto prospectivo,...

Mehr Frauen in die Medizintechnik

, Medical Technology

Im Rahmen der langjährigen Zusammenarbeit mit dem "Club Lise" hießen die BIOTRONIK Mitarbeiterinnen Sofia Binias und Ulrike Heiden naturwissenschaftlic­h...

BIOTRONIK Announces First Enrollments in New Study Evaluating Reduction of Thromboembolic Events via GoldTip Ablation

, Medical Technology

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today the first enrollments in its prospective, multi-center,...

Reduziert GoldTip-Katheterablation thromboembolische Ereignisse? Erster Patient in Reduce-TE Studie eingeschlossen

, Medical Technology

BIOTRONIK, ein führender Hersteller kardiovaskulärer Medizintechnik, gab heute den Start der prospektiven, multizentrischen, internationalen...

BIOTRONIK lance ses nouvelles gammes DAI et CRT-D ProMRI avec sonde Sentus QP, pour un accès aux IRM encore plus large

, Medical Technology

BIOTRONIK, l'un des fabricants leaders de dispositifs cardiovasculaires, a annoncé aujourd'hui la commercialisation de sa nouvelle gamme de défibrillateurs...

Media

Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
BIOTRONIK
Woermannkehre 1
D - 12359 Berlin



Ansprechpartner

Frau Manuela Schildwächter


Communications & PR Manager
BIOTRONIK SE & Co. KG

Telefon +49 (30) 689051414


Frau Sarah Wandrey


Communications & PR Manager
Marketing Strategy & Communications

Telefon +49 (30) 68905-1475
Fax +49 (30) 6890596-1475


alle Ansprechpartner
Disclaimer